Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovate (VATE) EBITDA (2016 - 2025)

Innovate has reported EBITDA over the past 16 years, most recently at $20.1 million for Q4 2025.

  • For Q4 2025, EBITDA rose 136.47% year-over-year to $20.1 million; the TTM value through Dec 2025 reached $51.6 million, down 20.62%, while the annual FY2025 figure was $51.6 million, 20.62% down from the prior year.
  • EBITDA for Q4 2025 was $20.1 million at Innovate, up from $11.8 million in the prior quarter.
  • Over five years, EBITDA peaked at $35.2 million in Q2 2024 and troughed at -$6.2 million in Q1 2021.
  • A 5-year average of $11.1 million and a median of $11.1 million in 2025 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: surged 345.83% in 2022 and later plummeted 70.45% in 2025.
  • Year by year, EBITDA stood at $14.2 million in 2021, then decreased by 9.86% to $12.8 million in 2022, then skyrocketed by 59.38% to $20.4 million in 2023, then crashed by 58.33% to $8.5 million in 2024, then surged by 136.47% to $20.1 million in 2025.
  • Business Quant data shows EBITDA for VATE at $20.1 million in Q4 2025, $11.8 million in Q3 2025, and $10.4 million in Q2 2025.